Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001209191-22-017206

General Counsel acquired 10,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barnett Valerie General Counsel 2022-03-04 Option exercise +10,500 $4.71 $49,455 12,400 D
Derivatives
Barnett Valerie General Counsel 2022-03-04 Option exercise · Stock Option (Right to Buy) −10,500 122,830 D
Loading xslF345X03/doc4.xml…